Stocksigma LogoStocksigma Logo

Injecto Polymers Reports Zero Deviation in IPO Fund Utilization for Q2FY27

Injecto Polymers Limited reported nil deviation or variation in the utilization of proceeds raised via its Initial Public Offer for the quarter ended 30th

Injecto Polymers Reports Zero Deviation in IPO Fund Utilization for Q2FY27

Injecto Polymers Ltd 路 Others (Uncategorized) 路 11 Nov 2026, 11:19 pm

Injecto Polymers Reports Zero Deviation in IPO Fund Utilization for Q2FY27 Injecto Polymers Limited reported nil deviation or variation in the utilization of proceeds raised via its Initial Public Offer for the quarter ended 30th Sep'26. Out of the total Rs 56.12 crore raised, the company utilized Rs 19.32 crore up to 30th Sep'26. Deployments include Rs 4.88 crore toward debt repayment against an allocated Rs 10.00 crore, Rs 7.25 crore for general corporate purposes versus Rs 7.28 crore allocated, and Rs 7.19 crore for issue expenses against Rs 8.34 crore planned. Capex allocation of Rs 30.50 crore remains unspent.

Original exchange filing (PDF)

More announcements from Injecto Polymers Ltd

All Injecto Polymers Ltd announcements